‌

US Patent 10502729 Diagnostic methods, therapeutic agents and uses thereof

Patent 10502729 was granted and assigned to Metabolon on December, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Metabolon

Current Assignee

Metabolon

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

105027290

Patent Inventor Names

Qibo Zhang0

Klaus Peter Adam0

Luke Miller0

Michael V. Milburn0

Anne M. Evans0

Jeffery E. Cobb0

Date of Patent

December 10, 2019

Patent Application Number

155488540

Date Filed

February 4, 2016

Patent Primary Examiner

‌

Rita J Desai

Patent abstract

The present invention provides a method for diagnosing a disease or disorder selected from the group consisting of insulin resistance, a metabolic disorder, diabetes and pre-diabetes in a subject. The method comprises the step of determining the level of a compound represented by structural formula (VI): or a salt thereof. Compositions and method of making thereof are also described.